OBJECTIVE: Describe the epidemiology of central line-associated bloodstream infections (CLABSIs) in neonatal intensive care units (NICUs) participating in a standardized and mandatory CLABSI surveillance program. DESIGN: Retrospective cohort. Setting. We included patients admitted (April 2007-March 2011) to 7 level II/III NICUs who developed a CLABSI (as defined by the National Healthcare Safety Network). METHODS: CLABSIs/1,000 central line-days and device utilization ratio were calculated; χ(2) test, Student t test, Kruskal-Wallis, and Poisson regression were used. RESULTS: Overall, 191 patients had 202 CLABSI episodes for a pooled mean rate of 4.0 CLABSIs/1,000 central line-days and a device utilization ratio of 0.20. Annual pooled mean CLABSI rates increased from 3.6 in 2007-2008 to 5.1 CLABSIs/1,000 central line-days in 2010-2011 (P - .01). The all-cause 30-day case fatality proportion was 8.9% (n = 17) and occurred a median of 8 days after CLABSI. Coagulase-negative Staphylococcus was identified in 112 (50.5%) cases. Staphylococcus aureus was identified in 22 cases, and 3 (13.6%) were resistant to methicillin. An underlying intra-abdominal pathology was found in 20% (40/202) of CLABSI cases, 50% of which were reported in the last year of study. When adjusted for mean birth weight, annual CLABSI incidence rates were independently associated with the proportion of intra-abdominal pathology (P = .007) and the proportion of pulmonary pathology (P = .016) reported. CONCLUSION: The increase in CLABSI rates in Quebec NICUs seems to be associated with an increased proportion of cases with underlying intra-abdominal and pulmonary pathologies, which needs further investigation.
OBJECTIVE: Describe the epidemiology of central line-associated bloodstream infections (CLABSIs) in neonatal intensive care units (NICUs) participating in a standardized and mandatory CLABSI surveillance program. DESIGN: Retrospective cohort. Setting. We included patients admitted (April 2007-March 2011) to 7 level II/III NICUs who developed a CLABSI (as defined by the National Healthcare Safety Network). METHODS: CLABSIs/1,000 central line-days and device utilization ratio were calculated; χ(2) test, Student t test, Kruskal-Wallis, and Poisson regression were used. RESULTS: Overall, 191 patients had 202 CLABSI episodes for a pooled mean rate of 4.0 CLABSIs/1,000 central line-days and a device utilization ratio of 0.20. Annual pooled mean CLABSI rates increased from 3.6 in 2007-2008 to 5.1 CLABSIs/1,000 central line-days in 2010-2011 (P - .01). The all-cause 30-day case fatality proportion was 8.9% (n = 17) and occurred a median of 8 days after CLABSI. Coagulase-negative Staphylococcus was identified in 112 (50.5%) cases. Staphylococcus aureus was identified in 22 cases, and 3 (13.6%) were resistant to methicillin. An underlying intra-abdominal pathology was found in 20% (40/202) of CLABSI cases, 50% of which were reported in the last year of study. When adjusted for mean birth weight, annual CLABSI incidence rates were independently associated with the proportion of intra-abdominal pathology (P = .007) and the proportion of pulmonary pathology (P = .016) reported. CONCLUSION: The increase in CLABSI rates in Quebec NICUs seems to be associated with an increased proportion of cases with underlying intra-abdominal and pulmonary pathologies, which needs further investigation.
Authors: Jasmine Chong; Caroline Quach; Ana C Blanchard; Philippe Guillaume Poliquin; George R Golding; Céline Laferrière; Simon Lévesque Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191
Authors: Susan E Coffin; Sarah B Klieger; Christopher Duggan; W Charles Huskins; Aaron M Milstone; Gail Potter-Bynoe; Bram Raphael; Thomas J Sandora; Xiaoyan Song; Danielle M Zerr; Grace M Lee Journal: Infect Control Hosp Epidemiol Date: 2014-10-02 Impact factor: 3.254
Authors: Viraj Ambalam; Anna C Sick-Samuels; Julia Johnson; Elizabeth Colantuoni; Avinash Gadala; Clare Rock; Aaron M Milstone Journal: Am J Infect Control Date: 2021-04-02 Impact factor: 4.303
Authors: Yue Qu; Yali Li; David R Cameron; Christopher D Easton; Xuebo Zhu; Minli Zhu; Mario Salwiczek; Benjamin W Muir; Helmut Thissen; Andrew Daley; John S Forsythe; Anton Y Peleg; Trevor Lithgow Journal: Front Microbiol Date: 2020-05-13 Impact factor: 5.640
Authors: Sophie J Jansen; Alieke van der Hoeven; Thomas van den Akker; Marieke Veenhof; Erik G J von Asmuth; Karin Ellen Veldkamp; Monique Rijken; Martha van der Beek; Vincent Bekker; Enrico Lopriore Journal: Eur J Clin Microbiol Infect Dis Date: 2022-09-30 Impact factor: 5.103
Authors: Gerdina H Dubbink-Verheij; Vincent Bekker; Iris C M Pelsma; Erik W van Zwet; Vivianne E H J Smits-Wintjens; Sylke J Steggerda; Arjan B Te Pas; Enrico Lopriore Journal: Front Pediatr Date: 2017-06-20 Impact factor: 3.418